Testing for BRCA and HRD in Ovarian Cancer
1 Views
administrator
07/08/23
Bradley J. Monk, MD, FACOG, FACS, reacts to advances in molecular testing used to identify predictive biomarkers to guide treatment decisions in newly diagnosed advanced ovarian cancer.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Show more
Facebook Comments
No comments found